Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling et al., eLife, doi:10.7554/eLife.83201 (preprint 7/19/2022)
https://c19ivm.org/schilling.html